SCHEMBL21392785

SCHEMBL21392785

BBN(/N=C(\C)c1ccccc1)C(C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ G6PC1 P35575 1/20 0.41
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ NOS2 P35228 1/20 0.37
▸ TRPM8 Q7Z2W7 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ LMNA P02545 3/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MTOR P42345 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ATM Q13315 1/20 0.32
▸ METTL3 Q86U44 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21401699 0.77 G6PC1 (0.46) G6PC1MEN1KMT2ANOS2TRPM8
SCHEMBL21401831 0.76 G6PC1 (0.45) G6PC1MEN1KMT2ANOS2TRPM8
SCHEMBL6911592 0.70 ALOX5 (0.44) G6PC1MEN1KMT2ATRPM8ALOX5
SCHEMBL3091964 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1
SCHEMBL6898289 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1
SCHEMBL6901967 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1
SCHEMBL12269567 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1
SCHEMBL3091960 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1
SCHEMBL6901975 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1
SCHEMBL3091971 0.69 NOS2 (0.60) NOS2LMNAMAPK1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 — — US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 G6PC1 2972/4885MEN1 4319/4885KMT2A 3168/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 G6PC1 2972/4885MEN1 4319/4885KMT2A 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback